MAGENTA THERAPEUTICS INC (MGTA) Stock Analyst Earnings Estimates
NASDAQ:MGTA - Nasdaq - US55910K1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 184.60% | N/A 55.26% | N/A 32.09% | ||||||||
| EBITDA YoY % growth | -9.26M | -35.347M -281.72% | -59.083M -67.15% | -81.129M -37.31% | -76.722M 5.43% | -72.672M 5.28% | -78.977M -8.68% | N/A 11.62% | N/A -13.18% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.27M | -35.727M -285.40% | -59.963M -67.84% | -82.969M -38.37% | -78.7M 5.15% | -74.692M 5.09% | -80.902M -8.31% | N/A 27.01% | N/A 100.00% | N/A | N/A | N/A | N/A 89.61% | N/A 389.57% | N/A 119.03% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.05 49.09% | -1.74 15.12% | -1.31 24.71% | -1.29 1.53% | N/A 34.37% | N/A 102.41% | N/A | N/A | N/A -4,100.00% | N/A 77.50% | N/A 361.11% | N/A 104.26% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.31 -13.33% | 0.00 100.00% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -18.753M -8.69% | 100.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.05 82.76% | -0.19 | 0.14 | 74.20% |
| Q1 2023 Q2Q % growth | -0.48 -23.08% | -0.42 | -0.06 | -14.78% |
| Q4 2022 Q2Q % growth | -0.34 -3.03% | -0.28 | -0.06 | -23.46% |
| Q3 2022 Q2Q % growth | -0.27 10.00% | -0.31 | 0.04 | 11.76% |
| Q2 2022 Q2Q % growth | -0.29 9.38% | -0.34 | 0.05 | 13.84% |
| Q1 2022 Q2Q % growth | -0.39 -8.33% | -0.32 | -0.07 | -22.21% |
| Q4 2021 Q2Q % growth | -0.33 13.16% | -0.33 | 0.00 | -0.58% |
| Q3 2021 Q2Q % growth | -0.30 18.92% | -0.33 | 0.03 | 10.41% |
| Q2 2021 Q2Q % growth | -0.32 33.33% | -0.39 | 0.07 | 17.00% |
| Q1 2021 Q2Q % growth | -0.36 29.41% | -0.41 | 0.05 | 12.20% |
| Q4 2020 Q2Q % growth | -0.38 35.59% | -0.42 | 0.04 | 10.32% |
| Q3 2020 Q2Q % growth | -0.37 31.48% | -0.46 | 0.09 | 19.17% |
| Q2 2020 Q2Q % growth | -0.48 | -0.55 | 0.07 | 12.57% |
| Q1 2020 Q2Q % growth | -0.51 -15.91% | -0.61 | 0.10 | 15.79% |
| Q4 2019 Q2Q % growth | -0.59 | -0.60 | 0.01 | 2.35% |
| Q3 2019 Q2Q % growth | -0.54 | -0.55 | 0.01 | 2.36% |
| Q2 2019 Q2Q % growth | -0.48 | -0.54 | 0.06 | 10.70% |
| Q1 2019 Q2Q % growth | -0.44 | -0.59 | 0.15 | 24.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -100% | 0% | -74.74% |
| Revenue | N/A | N/A | N/A | N/A |